Quick Answer
EXAGEN INC. reported Diluted EPS of $0.93 per share (loss) for fiscal year 2025.
EXAGEN INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.93 | -12.0% |
| 2024 | -$0.83 | +38.1% |
| 2023 | -$1.34 | +51.6% |
| 2022 | -$2.77 | -64.9% |
| 2021 | -$1.68 | -27.3% |
| 2020 | -$1.32 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.31 | -10.7% | -47.6% |
| June 30, 2025 | -$0.21 | -31.2% | -5.0% |
| March 31, 2025 | -$0.20 | -5.3% | +28.6% |
| September 30, 2024 | -$0.28 | +9.7% | -75.0% |
| June 30, 2024 | -$0.16 | +42.9% | +15.8% |
| March 31, 2024 | -$0.19 | +56.8% | +38.7% |
| September 30, 2023 | -$0.31 | +34.0% | -10.7% |
| June 30, 2023 | -$0.28 | +67.4% | +36.4% |
- EXAGEN INC. showed a decrease of -12.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, EXAGEN INC.’s diluted eps has grown by 29.5% (from $1.32 per share (loss) to $0.93 per share (loss)).
- The most recent figure is from EXAGEN INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: